Understanding cystic-fibrosis-related diabetes: Best thought of as insulin deficiency?

Journal of the Royal Society of Medicine, Supplement

Volumn 97, Issue 44, 2004, Pages 26-35

  Dobson, Lee ^a   Sheldon, Christopher D ^a   Hattersley, Andrew T ^b  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ANTIDIABETIC AGENT; BIGUANIDE; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; REPAGLINIDE; TOLBUTAMIDE;

ABDOMINAL DISCOMFORT; ANOREXIA; CELL FUNCTION; CLEARANCE; CLINICAL TRIAL; CONFERENCE PAPER; CYSTIC FIBROSIS; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIARRHEA; DIET; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; GLUCOSE URINE LEVEL; HUMAN; HYPOXIA; INCIDENCE; INSULIN DEFICIENCY; INSULIN RESISTANCE; LACTIC ACIDOSIS; MORBIDITY; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREVALENCE; SCREENING;

BLOOD GLUCOSE; CYSTIC FIBROSIS; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 2542504822     PISSN: 02675331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (78)

1. Dodge JA, Morison S, Lewis PA, et al. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child 1997;77:493-6
2. Rommens JM, Iannuzzi MC, Kerem BS, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-65
3. Shwachman H, Leubner H, Catzel P. Mucoviscidosis. Adv Pediatr 1955;7:249-2
4. Rosan RC, Shwachman H, Kulczycki L. Diabetes mellitus and cystic fibrosis of the pancreas. Am J Dis Child 1962;104:625-63
5. Cystic Fibrosis Foundation Patient Registry. Annual Report Data 1997. Bethesda, MD: Cystic Fibrosis Foundation, 1998
6. World Health Organization. Diagnosis and Classification of Diabetes. Geneva: World Health Organization, 1999
7. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97
8. Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis (CF) patients. Diabet Med. in press
9. Allend HF, Gay EC, Klingensmith GJ, et al. Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the US. Diabetes Care 1998;21:943-8
10. Stutchfield PR, O'Halloran S, Teale JD, et al. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child 1987;62:805-10
11. Lanng S, Hansen A, Thorsteinsson B, et al. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995;311:655-9
12. Yung B, Kemp M, Hooper J, et al. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax 1999;54:40-3
13. DeSchepper J, Hachimi-Idrissi S, Smitz J, et al. First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters. Horm Res 1992;38:260-3
14. Solomon MP, Wilson DC, Corey M, et al. Glucose intolerance in children with cystic fibrosis. J Pediatr 2003;142:182-32
15. Hardin DS, Moran A. Diabetes mellitus in cystic fibrosis. Endocrinol Metab Clin North Am 1999;28:787-800
16. Moran A, Hardin DS, Rodman HM, et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus. A consensus conference report. Diabetes Res Clin Pract 1999;45:61-73
17. Dobson L, Hattersley AT, Tiley S, et al. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child 2002;87:430-1
18. WHO Study Group on Diabetes Mellitus. Diabetes mellitus. WHO Techn Rep Ser 1985;727:1-113
19. Holl RW, Buck C, Cario H, et al. Diagnosis of diabetes in cystic fibrosis and thalassemia major. Diabetes Care 1998;21:671-2
20. Boland E, Monsod T, Delucia M, et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24:1858-62
21. Mastrototaro JJ. The MiniMed continuous glucose monitoring system. Diabetes Technol Ther 2000;2(Suppl 1):S13-8
22. Pickup JC, Shaw GW, Claremont DJ. In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer. Diabetologia 1989;32:213-7
23. Bantle JP, Thomas W. Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid. J Lab Clin Med 1997;130:436-41
24. Gross TM, Mastrototaro JJ. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2000;2(Suppl 1):S19-26
25. Dobson L, Sheldon CD, Hattersley AT. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care 2003;26:1940-1
26. National Institute of Arthritis MaDD. Cystic Fibrosis: a Disease in Search of Ideas. Clinical sciences vol 2. Bethesda, MD: National Institutes of Health, 1979:33-4
27. Frase LL, Strickland AD, Kackel GW, et al. Enhanced glucose absorption in the jejunum of patients with cystic fibrosis. Gastroenterology 1985;88:478-84
28. Yung B, Hodson ME. Diabetes in cystic fibrosis. J R Soc Med 1999;92(Suppl 37):35-40
29. Marshall BC, Butler SM, Stoddard M, et al. CF-related diabetes mellitus. Pediatr Pulmonol 2000;Suppl 20:133-4
30. Rodman HM, Doershuk CF, Roland JM. The interaction of two diseases: diabetes mellitus and cystic fibrosis. Medicine 1986;65:389-97
31. Reisman J, Corey M, Canny G, et al. Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics 1990;86:374-7
32. Finkelstein SM, Wielinski CL, Elliott GR, et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1998;112:373-7
33. Bertele-Harms RM, Harms HK. Sulphonylureas in the treatment of CFRD. A 15-year experience. Pediatr Pulmonol 1996;13:380A
34. Culler FL, McKean LP, Buchanan CJ, et al. Glipizide treatment of patients with CF and impaired glucose tolerance. J Pediatr Gastroenterol Nutr 1993;18:375-8
35. Chazan BI, Balodimos MC, Holsclaw DS, et al. Microcirculation in young adults with cystic fibrosis: retinal and conjunctival vascular changes in relation to diabetes. J Pediatr 1970;77:86-92
36. Dolan TFJ. Microangiopathy in a young adult with cystic fibrosis and diabetes mellitus. N Engl J Med 1986;314:991-2
37. Allen JL. Progressive nephropathy in a patient with cystic fibrosis and diabetes. N Engl J Med 1986;315:764
38. Sullivan MM, Denning CR. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics 1989;84:642-7
39. Lanng S, Thosteinnson B, Lund-Andersen C, et al. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994;84:72-7
40. Rosenecker J, Hofler R, Steinkamp G, et al. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001;6:345-50
41. Dobson L, Stride A, Bingham C, et al. Microalbuminuria as a screening tool in cystic fibrosis related diabetes. Arch Dis Child, submitted
42. Schlesinger DM, Holsclaw DS, Fyfe B. Generalised atherosclerosis in an adult with CF and diabetes mellitus. Pediatr Pulmonol 1997;Suppl 14:365A
43. Lanng S, Thosteinnson B, Nerup J, et al. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992;15:684-87
44. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Resp Crit Care Medicine 2000;162:891-5
45. Rolon M, Benali K, Munck A, et al. Cystic fibrosis related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001;90:860-7
46. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M. Insulin improves clinical status of patients with cystic-fibrosis-related-diabetes mellitus. Acta Paediatr 2001;90:515-9
47. Lanng S, Thosteinnson B, Nerup J, et al. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 1994;83:849-53
48. Lanng S, Thosteinnson B, Roder ME, et al. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol 1993;128:207-14
49. Miller M, Ward L, Thomas BJ, et al. Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis. Am J Clin Nutr 1982;36:492-9
50. Moran A, Milla C, Ducret R, et al. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance. Diabetes 2001;50:1336-43
51. Moran A, Diem P, Klein DJ, et al. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991;118:715-23
52. Hamdi I, Green M, Shneerson JM, et al. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis. Clin Endocrinol 1993;39:21-6
53. Cucinotta D, DeLuca F, Arrigo T, et al. First-phase insulin response to intravenous glucose in cystic fibrosis patients with different degrees of glucose tolerance. J Pediatr Endocrinol 1994;7:13-17
54. Garagorri JM, Rodriguez G, Ros L, et al. Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors. J Pediatr Endocrinol Metab 2001;14:53-60
55. Handwerger S, Roth J, Gorden P, et al. Glucose intolerance in cystic fibrosis. N Engl J Med 1969;281:451-61
56. Wilmshurst EG, Soeldner JS, Holsclaw DS, et al. Endogenous and exogenous insulin responses in patients with cystic fibrosis. Pediatrics 1975;55:75-82
57. Lippe BM, Sperling MA, Dooley RR. Pancreatic alpha and beta cell functions in cystic fibrosis. J Pediatr 1977;90:751-5
58. Cucinotta D, Conti Nibali S, Arrigo T, et al. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res 1990;34:33-8
59. Yung B, Noormohamed FH, Kemp M, et al. Cystic fibrosis related diabetes: the role of peripheral insulin resistance and B-cell dysfunction. Diabet Med 2002;19:221-6
60. Redmond AO, Buchanan KD, Trimble ER. Insulin and glucagon response to arginine infusion in cystic fibrosis. Acta Paediatr Scand 1977;66:199-204
61. Iannucci A, Mukai K, Johnson D, et al. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol 1984;15:278-84
62. Kopito LE, Shwachman H. The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr Res 1976;10:742-9
63. Lohr M, Goertchen P, Nizze H, et al. Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch A Pathol Anat Histopathol 1989;414:179-85
64. Soejima K, Landing BH. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr Pathol 1986;6:25-46
65. Abdul-Karim FW, Dahms BB, Velasco ME, et al. Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study. Arch Pathol Lab Med 1986;110:602-6
66. Couce M, O'Brien TD, Moran A, et al. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab 1996;81:1267-72
67. Cucinotta D, De Luca F, Gigante A, et al. No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol 1994;130:253-8
68. Lanng S, Thorsteinsson B, Roder ME, et al. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol (Oxf) 1994;41:217-23
69. Moran A, Pyzdrowski KL, Weinreb J, et al. Insulin sensitivity in cystic fibrosis. Diabetes 1994;43:1020-6
70. Austin A, Kalhan SC, Orenstein D, et al. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab 1994;79:80-5
71. Ahmad T, Nelson R, Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism 1994;43:163-7
72. Taylor CJ, Baxter PS, Hardcastle J, et al. Glucose intolerance in cystic fibrosis. Arch Dis Child 1989;64:759
73. Zipf WB, Kien CL, Horswill CA, et al. Effects of tolbutamide on growth and body composition of nondiabetic children with cystic fibrosis. Pediatr Res 1991;30:309-14
74. Hinds A, Sheehan AG, Parsons HG. Tolbutamide causes a modest increase in insulin secretion in CF patients with impaired glucose tolerance. Metab Clin Exp 1995;44:13-18
75. Rosenecker J, Eichler I, Barmeier H, et al. Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. Pediatr Pulmonol 2001;32:351-5
76. + channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol 1992;100:573-91
77. Kentrup H, Bongers H, Spengler M, et al. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance. Eur J Pediatr 1999;158:455-9
78. Moran A, Phillips J, Milla C. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care 2001;24:1706-10